摘要 |
The present invention relates to solid forms of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2- methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1) in substantially crystalline form (Form A) or amorphous form, pharmaceutical compositions thereof, and methods of treatment therewith. |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED;KESHAVARZ-SHOKRI, ALI;ZHANG, BEILI;ALCACIO, TIM, EDWARD;LEE, ELAINE, CHUNGMIN;ZHANG, YUEGANG;KRAWIEC, MARIUSZ |
发明人 |
KESHAVARZ-SHOKRI, ALI;ZHANG, BEILI;ALCACIO, TIM, EDWARD;LEE, ELAINE, CHUNGMIN;ZHANG, YUEGANG;KRAWIEC, MARIUSZ |